Molina Healthcare: It Looks Worse Than It Feels, Long-Term Prognosis Improves

Molina Healthcare, Inc. MOH 1.18% shareholders were disappointed by the company’s second-quarter earnings miss that sent shares tumbling more than 8 percent Thursday morning. However, there may be a silver lining to the company’s second quarter for long-term investors.

According to Deutsche Bank analyst Chris Rigg, Molina management took a big step in the quarter in repositioning the company for a more stable performance in the future.

“More importantly, we are actually increasing our 2018 EPS estimate to $4.30 ($3.12) to take into account some softness in the core Medicaid business offset by significant improvement in the ACA business and cost savings from the headcount reductions,” Rigg wrote (see his track record here).

Rigg says almost all the issues weighing on Molina in the second quarter as either temporary or easily remedied via pricing or design modifications.

Deutsche Bank notes five key items that led to the earnings miss:

  • A $72 million impairment charge related to the Pathways buyout from 2015.
  • $85 million in out-of-period medical costs in Florida, Illinois, New Mexico and Puerto Rico.
  • $44 million in negative ACA risk adjustments.
  • $78 million to the premium deficiency reserve, mostly to service Florida, Utah, Washington and Wisconsin.
  • $43 million in restructuring costs.

Heading into 2018, Molina already plans to raise its premiums by 55 percent and cut service in its two least profitable states.

While there are still plenty of risks and unpredictability associated with Molina, Deutsche Bank believes…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common SenseI don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!